https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/4tbpmbe0/010926-omd-web-covers-staff.jpg
Ophthalmology Management
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/iwrbuuc4/0326-cover-final.jpg
Retinal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/1hjnp2rj/0326_gp_cover.jpg
Glaucoma Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/0jsmmz3o/op_1025_cover_final.jpg
Ophthalmic Professional
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/d0ojx5r2/oasc_0326_cover.jpg
The Ophthalmic ASC
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/aqbjxwjw/pp-cover.jpg
Presbyopia Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/npjdtl1w/cp_november_cover.jpg
Corneal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://glaucomaphysician.net/media/mvqdq2hc/nrp_cover_october_2024.jpg
New Retinal Physician
February 19, 2026 - February 22, 2026
Rancho Mirage, California
March 6, 2026
At the Glaucoma Innovation Summit, Eydie Miller-Ellis, MD, discussed how this next-generation bimatoprost formulation lowers IOP while minimizing ocular surface irritation.
March 2, 2026
At the American Glaucoma Society Resident Research Forum, Naveen Karthik, MD, examines usability and accessibility metrics across major glaucoma organization websites.
February 27, 2026
Avisi Technologies founder and CEO Rui Jing Jiang shares insights on the company’s VisiPlate shunt and other nanotechnologies, the VITA and SAPPHIRE trials, and the company’s vision for comprehensive glaucoma care.
February 24, 2026
At AGS 2026, Douglas J. Rhee, MD, provided a practical overview of device regulation and its implications for MIGS adoption and reimbursement.
February 24, 2026
Preliminary trials in India suggest Tulip may help lower eye pressure, says Donald Schwartz, MD.
February 23, 2026
Researchers from the University of Illinois College of Medicine found that both approaches reduce IOP, lower medications, and improve visual acuity.
February 22, 2026
At AGS 2026, Andrew Pouw, MD, explained how changes to practice expense and work RVUs significantly lower Medicare reimbursement for surgeons.
February 22, 2026
At the American Glaucoma Society meeting, Aakriti Garg Shukla, MD, highlighted how small changes in surgical and clinic workflows can meaningfully improve sustainability across ophthalmic care.
February 21, 2026
At AGS 2026, Barbara Wirostko, MD, FARVO, reviewed top-line data on QLS-111, including additive IOP lowering on latanoprost.
February 21, 2026
A University of Maryland study finds that retinal blood-flow autoregulation may signal early glaucoma before structural damage or vision loss is detectable.
February 21, 2026
At AGS 2026, Lorraine M. Provencher, MD, outlined practical strategies for using patient assistance programs to reduce medication costs.
February 21, 2026
Researchers from Emory University reported meaningful IOP control and reduced glaucoma medications when combined with cataract surgery.
February 20, 2026
Newer artificial intelligence tools are designed to automate routine administrative tasks and improve practice efficiency.
February 20, 2026
In the 2026 AGS Lecture, Louis R. Pasquale, MD, FARVO, discussed how genetics, metabolism, and understanding the impact of myopia on the lamina support system may redefine optic nerve protection.
February 20, 2026
Cecilia S. Lee, MD, MS, explores how deep learning models could enable earlier intervention and better outcomes.
February 20, 2026
At AGS 2026, Ian F. Pitha, MD, PhD, discussed the current role of MIBS and reviewed investigational devices under development.
February 20, 2026
Data presented at AGS 2026 suggest the Calibreye system may offer pressure and medication reduction comparable to existing drainage implants.
February 20, 2026
Steven R. Sarkisian Jr., MD, reviews early results with the extended-release travoprost implant.
February 20, 2026
At AGS 2026, Rachel Simpson, MD, highlighted the latest investigational technologies in minimally invasive glaucoma surgery.
February 20, 2026
The AGS Cares program matches patients in need with volunteer surgeons across the United States.
February 20, 2026
A small prospective study using home tonometry showed sustained reductions in intraocular pressure variability through 18 months.
February 20, 2026
A retrospective observational study of more than 279,000 eyes may help guide patient selection for repeat SLT.